Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046059 · ClinicalTrials.gov registry record
Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 3,481
- Enrollment target
NCT00046059 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 3,481 participants.
The verdict
NCT00046059 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 3,481 participants
- Enrollment target
Study Summary
Attention Deficit Hyperactivity Disorder (ADHD) is the most common behavioral disorder in childhood, affecting 3-5% of children between the ages of 7 and 17. Family studies suggest that there is a genetic component to ADHD. Scientists believe that it is a complex disorder in which two or more genes may be involved. Potentially eligible families will be asked to give written consent to participate and will be asked to complete questionnaires for each member in the family. In addition, an interview will be administered to the parent of minors enrolled in the study to determine their eligibility for being in the study. This screening tool is computerized and will take approximately 45 minutes to administer per child. Once screenings are completed, a blood collection kit will be sent to the family to take to their local medical care provider, have blood samples drawn and sent to NIH. There is no cost to the family to participate. We would like to enroll entire families, with both parents and all children.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,481 participants |
| Start Date | 2000-02-08 |
| Est. Completion | 2020-01-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00046059
The ClinicalTrials.gov registry entry for NCT00046059 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,481 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00046059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00046059 about?
NCT00046059 is a clinical study titled "Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)". Attention Deficit Hyperactivity Disorder (ADHD) is the most common behavioral disorder in childhood, affecting 3-5% of children between the ages of 7 and 17. Family studies suggest that there is a genetic component to ADHD. Scientists believe that it is a complex disorder in which two or more genes ...
What is the current status of trial NCT00046059?
This trial is currently completed. The enrollment target is 3,481 participants. The study started on 2000-02-08. Estimated completion is 2020-01-24.
Who is sponsoring clinical trial NCT00046059?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.